| Development and validation of a predictive model for chemotherapy-associated thrombosis AA Khorana, NM Kuderer, E Culakova, GH Lyman, CW Francis Blood, The Journal of the American Society of Hematology 111 (10), 4902-4907, 2008 | 2335 | 2008 |
| Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy AA Khorana, CW Francis, E Culakova, NM Kuderer, GH Lyman Journal of Thrombosis and Haemostasis 5 (3), 632-634, 2007 | 1875 | 2007 |
| Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients AA Khorana, CW Francis, E Culakova, NM Kuderer, GH Lyman Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 1049 | 2007 |
| Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study AA Khorana, CW Francis, E Culakova, GH Lyman Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 712 | 2005 |
| Thromboembolism in hospitalized neutropenic cancer patients AA Khorana, CW Francis, E Culakova, RI Fisher, NM Kuderer, GH Lyman Journal of Clinical Oncology 24 (3), 484-490, 2006 | 623 | 2006 |
| Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer AA Khorana, CW Francis, N Blumberg, E Culakova, MA Refaai, ... Archives of internal medicine 168 (21), 2377-2381, 2008 | 475 | 2008 |
| Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study SG Mohile, MR Mohamed, H Xu, E Culakova, KP Loh, A Magnuson, ... The Lancet 398 (10314), 1894-1904, 2021 | 308 | 2021 |
| Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial IR Kleckner, C Kamen, JS Gewandter, NA Mohile, CE Heckler, ... Supportive Care in Cancer 26 (4), 1019-1028, 2018 | 302 | 2018 |
| Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy GH Lyman, NM Kuderer, J Crawford, DA Wolff, E Culakova, ... Cancer 117 (9), 1917-1927, 2011 | 287 | 2011 |
| Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice J Crawford, DC Dale, NM Kuderer, E Culakova, MS Poniewierski, D Wolff, ... Journal of the National Comprehensive Cancer Network 6 (2), 109-118, 2008 | 283 | 2008 |
| Communication with older patients with cancer using geriatric assessment: a cluster-randomized clinical trial from the National Cancer Institute Community Oncology Research Program SG Mohile, RM Epstein, A Hurria, CE Heckler, B Canin, E Culakova, ... JAMA oncology 6 (2), 196-204, 2020 | 221 | 2020 |
| The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials GH Lyman, DC Dale, E Culakova, MS Poniewierski, DA Wolff, ... Annals of oncology 24 (10), 2475-2484, 2013 | 219 | 2013 |
| Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens JJ Griggs, E Culakova, MES Sorbero, MS Poniewierski, DA Wolff, ... Journal of clinical oncology 25 (18), 2522-2527, 2007 | 165 | 2007 |
| Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer GH Lyman, E Culakova, MS Poniewierski, NM Kuderer Thrombosis research 164, S112-S118, 2018 | 163 | 2018 |
| Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy M Shayne, J Crawford, DC Dale, E Culakova, GH Lyman Breast cancer research and treatment 100 (3), 255-262, 2006 | 160 | 2006 |
| Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy GC Connolly, AA Khorana, NM Kuderer, E Culakova, CW Francis, ... Thrombosis research 126 (2), 113-118, 2010 | 158 | 2010 |
| Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose LS Constine, N Tarbell, MM Hudson, C Schwartz, SG Fisher, AG Muhs, ... International Journal of Radiation Oncology* Biology* Physics 72 (1), 24-33, 2008 | 152 | 2008 |
| Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy M Shayne, E Culakova, MS Poniewierski, D Wolff, DC Dale, J Crawford, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 143 | 2007 |
| Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy JJ Griggs, E Culakova, MES Sorbero, M Van Ryn, MS Poniewierski, ... Journal of clinical oncology 25 (3), 277-284, 2007 | 142 | 2007 |
| Patterns of chemotherapy‐associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study E Culakova, R Thota, MS Poniewierski, NM Kuderer, AF Wogu, DC Dale, ... Cancer medicine 3 (2), 434-444, 2014 | 118 | 2014 |
